ViewRay's Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)

CLEVELAND, May 30, 2013 /PRNewswire/ -- Prabhakar Tripuraneni, MD, chief medical officer at ViewRay™ Incorporated and head of radiation oncology at Scripps Green Hospital in La Jolla, California, has been selected to receive a Gold Medal from the American Society for Radiation Oncology (ASTRO). The Gold Medal is ASTRO's highest honor, bestowed on highly regarded members who have made outstanding contributions to the field of radiation oncology. The award will be presented at ASTRO's 2013 Annual Meeting in September.

"Over the course of a long and distinguished career, Dr. Tripuraneni has made unique contributions as both a clinical scientist and tireless voluntary leader in the field of radiation oncology," said past ASTRO Gold Medalist Christopher Rose, MD, FASTRO, chief technical officer for Valley Radiotherapy Associates Medical Group and Vantage Oncology, Inc., and a member of ViewRay's Scientific Advisory Board. "With his tremendous energy, dedication and passion for excellence, Dr. Tripuraneni has set a standard for professional service that those of us who are privileged to call him friend attempt to emulate."

A practicing physician, Tripuraneni served as president of ASTRO in 2004–2005 and has been recognized as a fellow of both ASTRO and the American College of Radiology (ACR). He is a graduate of Guntur Medical College in South India and a pioneer in coronary vascular brachytherapy. In 2009 he became chief medical officer at ViewRay, a privately held medical device company.

"All of us at ViewRay would like to congratulate Dr. Tripuraneni on this outstanding achievement," said Chris A. Raanes, ViewRay president and CEO. "Dr. Tripuraneni's commitment to the field of radiation oncology is truly commendable, and ViewRay is fortunate to have the benefit of his medical expertise and guidance."

About ViewRay
ViewRay Incorporated of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. The ViewRay system provides continuous soft-tissue imaging during treatment, using MRI-guided radiotherapy, so that clinicians are able to see where the actual radiation dose is being delivered and adapt to changes in the patient's anatomy. For more information, visit http://www.viewray.com.

About ASTRO
ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. To learn more, visit http://www.astro.org.

ViewRay is a trademark of ViewRay Incorporated.

ViewRay acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the MRI Technology Enabling Expansion of MRI into Radiotherapy Guidance Project.

SOURCE ViewRay Incorporated